Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.

By T. Watson, E. Shantsila, Gregory Y. H. Lip. The Lancet, 2009

1,042 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010, background): “‘Abnormalities of blood constituents’ are well described in AF and include haemostatic and platelet activation, as well as inflammation and growth factor abnormalities.(29)”
Inflammation in atrial fibrillation. (2012, background): “Several studies have described an association between AF and abnormal prothrombotic plasma markers, including fibrinogen, von Willebrand factor (vWF), and soluble P-selectin, suggesting that the arrhythmia itself contributes to the development of a prothrombotic state (1).”
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. (2016, neutral): “flow mediated dilatation).(289) Abnormal blood flow in AF can be vi-”
Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events (2014, background): “of prolonged AF leading to atrial stasis, clot formation, and then embolism.(14) Some thromboembolic events may indeed”